NDC 67457-847

OGIVRI

Trastuzumab

OGIVRI is a Kit in the Human Prescription Drug category. It is labeled and distributed by Mylan Institutional Llc. The primary component is .

• Product ID: 67457-847_07ab2fd4-cfe5-4cff-81bf-499602e5999c
• NDC: 67457-847
• Product Type: Human Prescription Drug
• Proprietary Name: OGIVRI
• Generic Name: Trastuzumab
• Dosage Form: Kit
• Marketing Start Date: 2019-11-29
• Marketing Category: BLA / BLA
• Application Number: BLA761074
• Labeler Name: Mylan Institutional LLC
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 67457-847-44

1 KIT in 1 CARTON (67457-847-44) * 20 mL in 1 VIAL, MULTI-DOSE (67457-845-50) * 20 mL in 1 VIAL (67457-846-20)

• Marketing Start Date: 2019-11-29
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 67457-847-44 [67457084744]

OGIVRI KIT

• Marketing Category: BLA
• Application Number: BLA761074
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2019-11-29

Drug Details

NDC Crossover Matching brand name "OGIVRI" or generic name "Trastuzumab"

NDC	Brand Name	Generic Name
67457-845	OGIVRI	trastuzumab
67457-847	OGIVRI	trastuzumab
67457-991	OGIVRI	trastuzumab
50242-132	Herceptin	Trastuzumab
50242-134	Herceptin	Trastuzumab
50242-333	Herceptin	Trastuzumab
63459-303	HERZUMA	TRASTUZUMAB
63459-305	HERZUMA	TRASTUZUMAB
0006-5033	Ontruzant	trastuzumab
0069-0305	Trazimera-qyyp	trastuzumab